Paul G. Corn | MD Anderson Cancer Center

Dr. Paul Corn

Claim this profile

M D Anderson Cancer Center

Studies Prostate Cancer
Studies Prostate Adenocarcinoma
5 reported clinical trials
10 drugs studied

Area of expertise

1Prostate Cancer
Paul Corn has run 4 trials for Prostate Cancer. Some of their research focus areas include:
Stage IV
TP53 positive
TP53 negative
2Prostate Adenocarcinoma
Paul Corn has run 1 trial for Prostate Adenocarcinoma. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center
Image of trial facility.
MD Anderson In The Woodlands

Clinical Trials Paul Corn is currently running

Image of trial facility.

Carboplatin + Cabazitaxel

for Prostate Cancer

This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that has spread from where it first started (primary site) to other places in the body (metastatic). Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Chemotherapy drugs, such as cabazitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Prednisone is often given together with chemotherapy drugs. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs and to help the chemotherapy work. Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.
Recruiting2 awards Phase 35 criteria

More about Paul Corn

Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Paul Corn has experience with
  • Abiraterone Acetate
  • Prednisone
  • Cabazitaxel
  • Apalutamide
  • Erdafitinib
  • Cabozantinib
Breakdown of trials Paul Corn has run
Prostate Cancer
Prostate Adenocarcinoma
Prostate Carcinoma
Bone Metastasis
Kidney Cancer

Other Doctors you might be interested in

Rebecca Harrison, MDBC Cancer - The Vancouver Center
Qian Lu, MDM D Anderson Cancer Center
Lois M RamondettaM D Anderson Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
What does Paul Corn specialize in?
Is Paul Corn currently recruiting for clinical trials?
Are there any treatments that Paul Corn has studied deeply?
What is the best way to schedule an appointment with Paul Corn?
What is the office address of Paul Corn?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security